Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-03-29
2009-06-09
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S265100, C544S243000, C544S280000
Reexamination Certificate
active
07544672
ABSTRACT:
Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs are described and demonstrated to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents used in the treatment and prevention of various HSP90 mediated disorders. Methods of synthesis and use of such compounds are also described and claimed.
REFERENCES:
patent: 3595955 (1971-07-01), Boer et al.
patent: 4261989 (1981-04-01), Sasaki et al.
patent: 4495190 (1985-01-01), Hagberg et al.
patent: 4533254 (1985-08-01), Cook et al.
patent: 4547573 (1985-10-01), Jung et al.
patent: 4617304 (1986-10-01), Ashton et al.
patent: 4699877 (1987-10-01), Cline et al.
patent: 4738958 (1988-04-01), Franco et al.
patent: 4748177 (1988-05-01), Sircar
patent: 4772606 (1988-09-01), Sircar
patent: 4774325 (1988-09-01), Casadio et al.
patent: 4806642 (1989-02-01), Sircar et al.
patent: 4918162 (1990-04-01), Slamon et al.
patent: 4921859 (1990-05-01), Sircar et al.
patent: 4923885 (1990-05-01), Hupe
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5002950 (1991-03-01), Malone et al.
patent: 5098906 (1992-03-01), Sircar et al.
patent: 5110818 (1992-05-01), Allgeier
patent: 5204353 (1993-04-01), Meier
patent: 5217866 (1993-06-01), Summerton et al.
patent: 5332744 (1994-07-01), Chakravarty
patent: 5369008 (1994-11-01), Arlinghaus
patent: 5387584 (1995-02-01), Schnur
patent: 5602156 (1997-02-01), Kohn et al.
patent: 5656629 (1997-08-01), Bacon et al.
patent: 5789394 (1998-08-01), Nugyen-Ba et al.
patent: 5846749 (1998-12-01), Slamon et al.
patent: 5861503 (1999-01-01), Barrio et al.
patent: 5917042 (1999-06-01), Daluge
patent: 5932566 (1999-08-01), Schnur et al.
patent: 5955610 (1999-09-01), Nguyen-Ba et al.
patent: 5994361 (1999-11-01), Penney
patent: 6005107 (1999-12-01), Nguyen-Ba et al.
patent: 6025126 (2000-02-01), Westbrook
patent: 6140374 (2000-10-01), May et al.
patent: 6143743 (2000-11-01), Wilde
patent: 6174875 (2001-01-01), DeFranco et al.
patent: 6177460 (2001-01-01), Camden
patent: 6210974 (2001-04-01), Gold
patent: 6262254 (2001-07-01), Barrio et al.
patent: 6333331 (2001-12-01), Moschel
patent: 6369092 (2002-04-01), Pamukcu
patent: 6444656 (2002-09-01), Nguyen-Ba et al.
patent: 6723727 (2004-04-01), Peyman et al.
patent: 7129244 (2006-10-01), Kasibhatla et al.
patent: 7138401 (2006-11-01), Kasibhatla et al.
patent: 7148228 (2006-12-01), Kasibhatla et al.
patent: 2002/0156277 (2002-10-01), Fick et al.
patent: 2002/0161014 (2002-10-01), Sadhu et al.
patent: 2003/0022864 (2003-01-01), Ishaq et al.
patent: 2003/0078413 (2003-04-01), Dempcy et al.
patent: 2003/0113331 (2003-06-01), Brooks et al.
patent: 2004/0063668 (2004-04-01), Choi et al.
patent: 2004/0097526 (2004-05-01), Gillespie et al.
patent: 2004/0102458 (2004-05-01), Chiosis et al.
patent: 2004/0116447 (2004-06-01), Gillespie et al.
patent: 2004/0241706 (2004-12-01), Shah et al.
patent: 2004/0242490 (2004-12-01), Brooks et al.
patent: 2005/0043239 (2005-02-01), Douangpanya et al.
patent: 2005/0049263 (2005-03-01), Kasibhatla et al.
patent: 2005/0107343 (2005-05-01), Kasibhatla et al.
patent: 2005/0113339 (2005-05-01), Kasibhatla et al.
patent: 2005/0113340 (2005-05-01), Kasibhatla et al.
patent: 2005/0119282 (2005-06-01), Kasibhatla et al.
patent: 2006/0035909 (2006-02-01), Fuksova et al.
patent: 2007/0111996 (2007-05-01), Kasibhatla et al.
patent: 2007/0111997 (2007-05-01), Kasibhatla et al.
patent: 2007/0173483 (2007-07-01), Kasibhatla et al.
patent: 2007/0185064 (2007-08-01), Kasibhatla et al.
patent: 55239 (1982-06-01), None
patent: 156559 (1985-10-01), None
patent: 159264 (1985-10-01), None
patent: 178178 (1986-04-01), None
patent: 206415 (1986-12-01), None
patent: 0184322 (1989-12-01), None
patent: 363320 (1990-04-01), None
patent: 0151528 (1990-07-01), None
patent: 465297 (1992-01-01), None
patent: 502690 (1992-09-01), None
patent: 565377 (1993-10-01), None
patent: 675123 (1995-10-01), None
patent: 06080670 (1994-03-01), None
patent: 08041035 (1996-02-01), None
patent: 08208687 (1996-08-01), None
patent: 09020776 (1997-01-01), None
patent: 09169758 (1997-06-01), None
patent: 10025294 (1998-01-01), None
patent: 2000-072733 (2000-03-01), None
patent: 2003-113181 (2003-04-01), None
patent: WO-86-05518 (1986-09-01), None
patent: WO-89-10923 (1989-11-01), None
patent: WO-92-05180 (1992-04-01), None
patent: WO-93-14215 (1993-07-01), None
patent: WO-95-07695 (1995-03-01), None
patent: WO-95-08327 (1995-03-01), None
patent: WO-98-01448 (1998-01-01), None
patent: W0-98-39344 (1998-09-01), None
patent: WO-98-51702 (1998-11-01), None
patent: WO-99-01454 (1999-01-01), None
patent: WO-99-02162 (1999-01-01), None
patent: WO-99-12927 (1999-03-01), None
patent: WO-1999-16465 (1999-04-01), None
patent: WO-99-24432 (1999-05-01), None
patent: WO-99-32122 (1999-07-01), None
patent: WO-99-51223 (1999-10-01), None
patent: WO-00-06573 (2000-02-01), None
patent: WO-00-37050 (2000-06-01), None
patent: WO-00-53394 (2000-07-01), None
patent: WO-00-44750 (2000-08-01), None
patent: WO-00-61578 (2000-10-01), None
patent: WO-00-68230 (2000-11-01), None
patent: WO-01-38584 (2001-05-01), None
patent: WO-01-49688 (2001-07-01), None
patent: WO-01-72779 (2001-10-01), None
patent: WO-02-085905 (2001-10-01), None
patent: WO-01-81346 (2001-11-01), None
patent: WO-02-02123 (2002-01-01), None
patent: WO-02-09696 (2002-02-01), None
patent: WO-02-36075 (2002-05-01), None
patent: WO-02-36171 (2002-05-01), None
patent: WO-02-055082 (2002-07-01), None
patent: WO-02-055083 (2002-07-01), None
patent: WO-02-055521 (2002-07-01), None
patent: WO-02-057288 (2002-07-01), None
patent: WO-02-069900 (2002-09-01), None
patent: WO-02-088079 (2002-11-01), None
patent: WO-02-088080 (2002-11-01), None
patent: WO-02-094196 (2002-11-01), None
patent: WO-02-102314 (2002-12-01), None
patent: WO-03-000200 (2003-01-01), None
patent: WO-03-002565 (2003-01-01), None
patent: WO-03-026571 (2003-04-01), None
patent: WO-03-035938 (2003-05-01), None
patent: WO-03-037860 (2003-05-01), None
patent: WO-03-041643 (2003-05-01), None
patent: WO-03-050295 (2003-06-01), None
patent: WO-03-056030 (2003-07-01), None
patent: WO-03-066005 (2003-08-01), None
patent: WO-03-072794 (2003-09-01), None
patent: WO-03-086381 (2003-10-01), None
patent: WO-03-106458 (2003-12-01), None
patent: WO-2004-014913 (2004-02-01), None
patent: WO-2004-024082 (2004-03-01), None
patent: WO-2004-029064 (2004-04-01), None
patent: WO-2004-087734 (2004-10-01), None
patent: WO-2005-012324 (2005-02-01), None
patent: WO-2005-016348 (2005-02-01), None
patent: WO-2005-016349 (2005-02-01), None
patent: WO-2005-028434 (2005-03-01), None
patent: WO-2005-028479 (2005-03-01), None
patent: WO-2005-058925 (2005-06-01), None
patent: WO-2005-058926 (2005-06-01), None
patent: WO-2005-067901 (2005-07-01), None
patent: WO-2005-079812 (2005-09-01), None
patent: WO-2005-085470 (2005-09-01), None
patent: WO-2005-092892 (2005-10-01), None
patent: WO-2006-105372 (2006-10-01), None
Bouma-ter Steege, J. et al., “Angiostatic Proteins and Peptides, ” Crit. Rev. Eukaryotic Gene Expression 11(4):319-333 (2001).
Hicklin, D.J. et al., “Monoclonal antibody strategies to block angiogenesis,” Drug Discovery Today 6(10):517-528 (2001).
Hodivala-Dilke,K. et al., “Integrins in angiogenesis: Multitalented molecules in a balancing act,” Cell Tissue Res. 314(1):131-144 (2003).
Kumar, C.C., “Integrin Alphavbeta3 as a Therapeutic Target for Blocking Tumor-induced Angiogenesis,” Curr. Drug Targets 4(2):123-131 (2003).
Marneros, A.G. et al., “The role of collagen-derived proteolytic fragments in angio genesis,” Matrix Biology 20:337-345 (2001).
Meerovitch, K. et al., “A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen,” Vasc. Pharma, 40:77-89 (2003).
Nimmanapalli et al., “Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apaptosis and differentiation of Bcr-Abl-positive human leukemic blasts,” Cancer Res. 61:1799-1804 (2001).
Schulte, T. “The benzoquinone ansamycin 17-allyamin
Biamonte Marco Antonio
Boehm Marcus F.
Kasibhatla Srinivas Rao
Shi Jiandong
Coleman Brenda L
Conforma Therapeutics Corporation
Finnegan
Moore Susanna
LandOfFree
Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4106895